“The upgrade reflects a significant turnaround for HFHS in fiscal 2015, based on audited results through Dec. 31, 2015,” said S&P analyst Kevin Holloran. “Management attributes the notable improvement to stable patient volumes and significant progress on its strength and sustainability plan to reduce costs and improve value.”
The outlook is stable, reflecting S&P’s expectation that throughout the rest of the outlook period, HFHS will sustain and build upon its recently improved operations.
More articles on healthcare finance:
Medicaid rebates for Mylan’s EpiPen challenged by US lawmakers
For-profit hospital stock report: Week of Aug. 29-Sept. 2
RCM tip of the day: Invest in human resources
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
